Pharmaxis: Chiesi Files Resubmission To Address FDA Bronchitol(Mannitol) Inhalation Powder Complete Response Letter - Arix Bioscience

Close Navigation

About Strategy Team Portfolio Insights Media Contact

Overlay

Pharmaxis: Chiesi Files Resubmission To Address FDA Bronchitol(Mannitol) Inhalation Powder Complete Response Letter

5th May 2020

Useful Tools

Download, print or share this article

Print

Print Article Email

Email

Print

Stay Updated

Add your email below to stay updated with useful and informative content from Arix and our portfolio companies

Share Article